Literature DB >> 16272315

Leucine aminopeptidase is not essential for trimming peptides in the cytosol or generating epitopes for MHC class I antigen presentation.

Charles F Towne1, Ian A York, Joost Neijssen, Margaret L Karow, Andrew J Murphy, David M Valenzuela, George D Yancopoulos, Jacques J Neefjes, Kenneth L Rock.   

Abstract

To detect viral infections and tumors, CD8+ T lymphocytes monitor cells for the presence of antigenic peptides bound to MHC class I molecules. The majority of MHC class I-presented peptides are generated from the cleavage of cellular and viral proteins by the ubiquitin-proteasome pathway. Many of the oligopeptides produced by this process are too long to stably bind to MHC class I molecules and require further trimming for presentation. Leucine aminopeptidase (LAP) is an IFN-inducible cytosolic aminopeptidase that can trim precursor peptides to mature epitopes and has been thought to play an important role in Ag presentation. To examine the role of LAP in generating MHC class I peptides in vivo, we generated LAP-deficient mice and LAP-deficient cell lines. These mutant mice and cells are viable and grow normally. The trimming of peptides in LAP-deficient cells is not reduced under basal conditions or after stimulation with IFN. Similarly, there is no reduction in presentation of peptides from precursor or full-length Ag constructs or in the overall supply of peptides from cellular proteins to MHC class I molecules even after stimulation with IFN. After viral infection, LAP-deficient mice generate normal CTL responses to seven epitopes from three different viruses. These data demonstrate that LAP is not an essential enzyme for generating most MHC class I-presented peptides and reveal redundancy in the function of cellular aminopeptidases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16272315     DOI: 10.4049/jimmunol.175.10.6605

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire.

Authors:  Nicholas J Steers; Jeffrey R Currier; Gustavo H Kijak; Robert C di Targiani; Ashima Saxena; Mary A Marovich; Jerome H Kim; Nelson L Michael; Carl R Alving; Mangala Rao
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

2.  Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance.

Authors:  Ian A York; Michael A Brehm; Sophia Zendzian; Charles F Towne; Kenneth L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

3.  Characterizing the specificity and cooperation of aminopeptidases in the cytosol and endoplasmic reticulum during MHC class I antigen presentation.

Authors:  Arron Hearn; Ian A York; Courtney Bishop; Kenneth L Rock
Journal:  J Immunol       Date:  2010-03-29       Impact factor: 5.422

Review 4.  Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins.

Authors:  Lloyd D Fricker
Journal:  Mol Biosyst       Date:  2010-04-28

5.  Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition.

Authors:  Jens Dinter; Pauline Gourdain; Nicole Y Lai; Ellen Duong; Edith Bracho-Sanchez; Marijana Rucevic; Paul H Liebesny; Yang Xu; Mariko Shimada; Musie Ghebremichael; Daniel G Kavanagh; Sylvie Le Gall
Journal:  J Immunol       Date:  2014-09-17       Impact factor: 5.422

Review 6.  Proteases in MHC class I presentation and cross-presentation.

Authors:  Kenneth L Rock; Diego J Farfán-Arribas; Lianjun Shen
Journal:  J Immunol       Date:  2010-01-01       Impact factor: 5.422

Review 7.  Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes.

Authors:  Nathalie Vigneron; Benoît J Van den Eynde
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

8.  Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo.

Authors:  Masahiro Kawahara; Ian A York; Arron Hearn; Diego Farfan; Kenneth L Rock
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

9.  Enhanced expression of interferon-gamma-induced antigen-processing machinery components in a spontaneously occurring cancer.

Authors:  Fulvia Cerruti; Marina Martano; Claudio Petterino; Enrico Bollo; Emanuela Morello; Renato Bruno; Paolo Buracco; Paolo Cascio
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

10.  A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1.

Authors:  George Mavridis; Richa Arya; Alexander Domnick; Jerome Zoidakis; Manousos Makridakis; Antonia Vlahou; Anastasia Mpakali; Angelos Lelis; Dimitris Georgiadis; Robert Tampé; Athanasios Papakyriakou; Lawrence J Stern; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2020-03-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.